Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Failing to provide bystander CPR legally riskier than performing the act

Bystanders of out-of-hospital cardiac arrests are more likely to face legal consequences for delaying or failing to provide CPR than for damages incurred during a resuscitation attempt.

Rising BP, cholesterol rates could cost millennials another $4.5K per year

An increase in the proportion of millennials with chronic health conditions like high blood pressure, high cholesterol and depression could cost the U.S. economy in a big way, the Daily Mail reported Nov. 7.

How moving CV care to the home could ease a period of economic transition in healthcare

Medicine is moving farther from its fee-for-service roots and closer to more individualized, value-based care—a phenomenon that could benefit a growing number of home-based care programs, according to data presented at MedAxiom’s CV Transforum.

Thumbnail

3 ways ‘Medicare for All’ could benefit CV research

The notion of a single-payer health system has been central to the 2020 presidential election, dominating much of the news cycle in recent months. According to an editorial published Nov. 4, that could be a good thing for physicians.

Thumbnail

CMS rule expands coverage of PCI at ambulatory centers

CMS has finalized a rule that states, come Jan. 1, it will begin paying for certain PCIs performed at ambulatory surgical centers in the U.S.

Thumbnail

Employers Clamp Down on Rising Healthcare Benefit Costs

Large employers are looking at virtual care and other options to help lower the costs of employee benefits. 

Thumbnail

Zantac recalls just ‘the tip of the iceberg’ for CV drug impurities

It’s been more than six weeks since Zantac and generic formulas of ranitidine were pulled from pharmacy shelves due to carcinogenic impurities, but physicians in Pittsburgh aren’t convinced the recalls are over.

Thumbnail

Apple hires another high-profile cardiologist

Apple has hired another big name in cardiology, signaling that it’s getting serious about its heart health initiatives, CNBC first reported Oct. 30.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.